C12Y 302/01059
Glucan endo-1,3-alpha-glucosidase
Official title: Glucan endo-1,3-alpha-glucosidase (3.2.1.59)
C12Y302/01059 (Glucan endo-1,3-alpha-glucosidase) appears on 17 US grants and 20 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 20
- Assignees
- 13
- Inventors
- 61
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 2 |
| 2022 | 2 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Small-scale robots for biofilm eradication7 Oct 2025US 12,433,295 B2The Trustees of the University of Pennsylvania
- Methods and compositions for treating mucosal tissue disorders26 Mar 2024US 11,938,166 B2The University of North Carolina at Chapel Hill
- Compositions and methods for inhibiting biofilm deposition and production15 Feb 2022US 11,246,819 B2The Trustees of the University of Pennsylvania
- Agarase-3,6-anhydro-L-galactosidase-arabinose isomerase enzyme complex and method for production of tagatose from agar using the same15 Feb 2022US 11,248,221 B2Korea University Research and Business Foundation
- Enzyme composition for treating dental plaque and plaque bacterial biofilms, and for the natural whitening of tooth enamel30 Jul 2026US 2026/0216042 A1
- Oral care composition comprising enzymes4 Jun 2026US 2026/0151318 A1Novozymes A/S
- Mutanases and oral care compositions comprising same18 Dec 2025US 2025/0381253 A1Novozymes A/S
- Methods and compositions for treating mucosal tissue disorders16 Jan 2025US 2025/0018003 A1The University of North Carolina at Chapel Hill
- Compositions and methods for inhibiting biofilm deposition and production3 Aug 2023US 2023/0241186 A1
Most cited
By later US patents
- Method for improving the solubility of vegetable proteins39US 5,989,600 ANovo Nordisk A/S · 1999
- Transgenic plants containing multiple disease resistance genes35US 5,530,187 AThe Salk Institute for Biological Studies · 1996
- Methods and compositions for treating mucosal tissue disorders17US 9,308,234 B2The University of North Carolina at Chapel Hill · 2016
- Oral composition containing dextranase and .alpha.-1,3 glucanase and a method for preventing and suppressing oral diseases using the same16US 4,438,093 AThe Research Foundation for Microbiai Diseases of Osaka University · 1984
- Mutanase14US 4,353,891 A1982